SPECT-CT Comparison of Lung Deposition using a System combining a Vibrating-mesh Nebulizer with a Valved Holding Chamber and a Conventional Jet Nebulizer: a Randomized Cross-over Study

PurposeTo compare in vivo the total and regional pulmonary deposition of aerosol particles generated by a new system combining a vibrating-mesh nebulizer with a specific valved holding chamber and constant-output jet nebulizer connected to a corrugated tube.MethodsCross-over study comparing aerosol delivery to the lungs using two nebulizers in 6 healthy male subjects: a vibrating-mesh nebulizer combined with a valved holding chamber (Aerogen Ultra®, Aerogen Ltd., Galway, Ireland) and a jet nebulizer connected to a corrugated tube (Opti-Mist Plus Nebulizer®, ConvaTec, Bridgewater, NJ). Nebulizers were filled with diethylenetriaminepentaacetic acid labelled with technetium-99 m (99mTc-DTPA, 2 mCi/4 mL). Pulmonary deposition of 99mTc-DTPA was measured by single-photon emission computed tomography combined with a low dose CT-scan (SPECT-CT).ResultsPulmonary aerosol deposition from SPECT-CT analysis was six times increased with the vibrating-mesh nebulizer as compared to the jet nebulizer (34.1 ± 6.0% versus 5.2 ± 1.1%, p < 0.001). However, aerosol penetration expressed as the three-dimensional normalized ratio of the outer and the inner regions of the lungs was similar between both nebulizers.ConclusionsThis study demonstrated the high superiority of the new system combining a vibrating-mesh nebulizer with a valved holding chamber to deliver nebulized particles into the lungs as comparted to a constant-output jet nebulizer with a corrugated tube.

[1]  A. Coates,et al.  Rapid pulmonary delivery of inhaled tobramycin for Pseudomonas infection in cystic fibrosis: A pilot project , 2008, Pediatric pulmonology.

[2]  A. Coates,et al.  Respiratory System Deposition with a Novel Aerosol Delivery System in Spontaneously Breathing Healthy Adults , 2013, Respiratory Care.

[3]  Ruben D. Restrepo,et al.  Performance comparison of nebulizer designs: constant-output, breath-enhanced, and dosimetric. , 2004, Respiratory care.

[4]  J. Kovarik,et al.  Lung deposition of inhaled tobramycin with eFlow rapid/LC Plus jet nebuliser in healthy and cystic fibrosis subjects. , 2011, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[5]  Gabriela Apiou-Sbirlea,et al.  The use of combined single photon emission computed tomography and X-ray computed tomography to assess the fate of inhaled aerosol. , 2011, Journal of aerosol medicine and pulmonary drug delivery.

[6]  G. Smaldone,et al.  Quantitative deposition of aerosolized gentamicin in cystic fibrosis. , 1987, The American review of respiratory disease.

[7]  BoukhettalaNabile,et al.  In vitro performance of spacers for aerosol delivery during adult mechanical ventilation. , 2015 .

[8]  H. Chan,et al.  Emerging inhalation aerosol devices and strategies: where are we headed? , 2014, Advanced drug delivery reviews.

[9]  Q. Lu,et al.  Efficacy of High-dose Nebulized Colistin in Ventilator-associated Pneumonia Caused by Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii , 2012, Anesthesiology.

[10]  S. Newman,et al.  Tissue Attenuation Corrections in Gamma Scintigraphy , 1997 .

[11]  P. Margaret.  Comparison of drug delivery from conventional versus "Venturi" nebulizers , 1997 .

[12]  L. B. Palmer,et al.  Aerosolized antibiotics in critically ill ventilated patients , 2009, Current opinion in critical care.

[13]  S. Willsie.  Improved treatment response to dornase alfa in cystic fibrosis patients using controlled inhalation , 2012 .

[14]  L. B. Palmer,et al.  Ventilator-associated infection: the role for inhaled antibiotics , 2015, Current opinion in pulmonary medicine.

[15]  G. Smaldone,et al.  Capturing the efficiency of vibrating mesh nebulizers: minimizing upper airway deposition. , 2014, Journal of Aerosol Medicine.

[16]  D. Hess,et al.  Nebulizers: principles and performance. , 2000, Respiratory care.

[17]  S. Newman,et al.  Efficient drug delivery to the lungs from a continuously operated open-vent nebulizer and low pressure compressor system. , 1994, The European respiratory journal.

[18]  D. Touw,et al.  Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: A European consensus. , 2009, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[19]  P. Diot,et al.  In vitro performance of spacers for aerosol delivery during adult mechanical ventilation. , 2015, Journal of aerosol medicine and pulmonary drug delivery.

[20]  G. Scheuch,et al.  Peripheral deposition of α1‐protease inhibitor using commercial inhalation devices , 2003, European Respiratory Journal.

[21]  R. Tiner,et al.  Aerosol drug delivery: developments in device design and clinical use , 2011, The Lancet.

[22]  K. Nikander,et al.  The evolution of spacers and valved holding chambers. , 2014, Journal of aerosol medicine and pulmonary drug delivery.

[23]  W. De Backer,et al.  Lung deposition of BDP/formoterol HFA pMDI in healthy volunteers, asthmatic, and COPD patients. , 2010, Journal of aerosol medicine and pulmonary drug delivery.

[24]  D. Bailey,et al.  Standardization of techniques for using single-photon emission computed tomography (SPECT) for aerosol deposition assessment of orally inhaled products. , 2012, Journal of aerosol medicine and pulmonary drug delivery.

[25]  2.9.18. PREPARATIONS FOR INHALATION: AERODYNAMIC ASSESSMENT OF FINE PARTICLES , 2004 .

[26]  R. Williams,et al.  Influence of particle size on regional lung deposition--what evidence is there? , 2011, International journal of pharmaceutics.

[27]  G. Paintaud,et al.  Pharmacokinetics of high-dose nebulized amikacin in mechanically ventilated healthy subjects , 2008, Intensive Care Medicine.

[28]  M. Wencker,et al.  Lung deposition of inhaled α1-proteinase inhibitor in cystic fibrosis and α1-antitrypsin deficiency , 2009, European Respiratory Journal.

[29]  A. Duarte.  Inhaled bronchodilator administration during mechanical ventilation. , 2004, Respiratory care.

[30]  G. Liistro,et al.  Effect of Drug Targeting Nebulization on Lung Deposition: A Randomized Crossover Scintigraphic Comparison Between Central and Peripheral Delivery , 2014, Respiratory Care.

[31]  A. Coates,et al.  A comparison of amount and speed of deposition between the PARI LC STAR® jet nebulizer and an investigational eFlow® nebulizer. , 2011, Journal of Aerosol Medicine.

[32]  S. Newman,et al.  Lung deposition from four nebulizers. , 1993, Respiratory medicine.

[33]  Joy Conway,et al.  Controlled, parametric, individualized, 2D and 3D imaging measurements of aerosol deposition in the respiratory tract of healthy human volunteers: in vivo data analysis. , 2014, Journal of aerosol medicine and pulmonary drug delivery.

[34]  J. Edelman,et al.  Lung Deposition of Alpha1-Proteinase Inhibitor (Human) (A1-PI[H]) Inhalation Solution Using Two Inhalation Modes of the I-neb Adaptive Aerosol Delivery (AAD) System in Healthy Subjects and Subjects with Cystic Fibrosis. , 2016, Journal of aerosol medicine and pulmonary drug delivery.

[35]  J. Fleming,et al.  Standardization of techniques for using planar (2D) imaging for aerosol deposition assessment of orally inhaled products. , 2012, Journal of aerosol medicine and pulmonary drug delivery.

[36]  J. I. Kennedy,et al.  Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia , 2009, Critical care.

[37]  V. Waters,et al.  Cystic fibrosis microbiology: Advances in antimicrobial therapy. , 2015, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[38]  J. Hankinson,et al.  Standardisation of spirometry , 2005, European Respiratory Journal.

[39]  Jan Karsten,et al.  Influence of different electrode belt positions on electrical impedance tomography imaging of regional ventilation: a prospective observational study , 2015, Critical Care.

[40]  Arzu Ari,et al.  Performance Comparisons of Jet and Mesh Nebulizers Using Different Interfaces in Simulated Spontaneously Breathing Adults and Children. , 2014, Journal of aerosol medicine and pulmonary drug delivery.

[41]  K. Nikander,et al.  Mode of breathing-tidal or slow and deep-through the I-neb Adaptive Aerosol Delivery (AAD) system affects lung deposition of (99m)Tc-DTPA. , 2010, Journal of aerosol medicine and pulmonary drug delivery.

[42]  M. Niederman,et al.  BAY41-6551 achieves bactericidal tracheal aspirate amikacin concentrations in mechanically ventilated patients with Gram-negative pneumonia , 2012, Intensive Care Medicine.

[43]  S. Leroy,et al.  Pharmacokinetics and safety of tobramycin administered by the PARI eFlow rapid nebulizer in cystic fibrosis. , 2009, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[44]  Kerstin Dahlström,et al.  Systemic availability and lung deposition of budesonide via three different nebulizers in adults. , 2003, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[45]  A. Coates,et al.  The challenges of quantitative measurement of lung deposition using 99mTc-DTPA from delivery systems with very different delivery times. , 2007, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[46]  J. D. Harrison,et al.  Radiation Dose to Patients from Radiopharmaceuticals , 1988 .

[47]  N. Byrne,et al.  Comparison of lung deposition of colomycin using the HaloLite and the Pari LC Plus nebulisers in patients with cystic fibrosis , 2003, Archives of disease in childhood.

[48]  P. Diot,et al.  Aerosol Deposition in Neonatal Ventilation , 2005, Pediatric Research.

[49]  A. Coates,et al.  Higher Tobramycin concentration and vibrating mesh technology can shorten antibiotic treatment time in cystic fibrosis , 2011, Pediatric pulmonology.

[50]  W. Bennett,et al.  Regional deposition of coarse particles and ventilation distribution in healthy subjects and patients with cystic fibrosis. , 2001, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[51]  M. O'Doherty,et al.  Variability in the measurement of nebulized aerosol deposition in man. , 1991, Clinical science.

[52]  M. O'Doherty,et al.  Effect of a spacer on pulmonary aerosol deposition from a jet nebuliser during mechanical ventilation. , 1995, Thorax.